Amwell appoints former Morgan Stanley MD Ricky Goldwasser to board, replacing Deval Patrick

American Well Corp

Goldwasser appointed as Class II director effective June 13, 2024; term ends at 2025 annual meeting.
She qualifies as independent under NYSE rules and will serve on the Audit Committee.
Goldwasser spent 15 years at Morgan Stanley as MD, head of US Healthcare Services & Technology Research and Investment Banking.
She replaces Deval Patrick, who served on the board since 2015 and helped guide the company through its 2020 IPO.
Eligible for standard non-employee director compensation as previously disclosed in the company's Q1 2024 Form 10-Q.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rivka "Ricky" Goldwasser

Class II Director

AMWL · American Well Corp

Effective: 2024-06-13
Filed: June 17, 2024, 7:59 PM ET

On June 13, 2024, the Board of Directors (the "Board") of American Well Corporation (the "Company") appointed Rivka "Ricky" Goldwasser as a Class II director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rivka "Ricky" Goldwasser was appointed as Class II Director at American Well Corp.

Action: appointed
Role: Class II Director

Exact text from the filing

On June 13, 2024, the Board of Directors (the "Board") of American Well Corporation (the "Company") appointed Rivka "Ricky" Goldwasser as a Class II director of the Company.

View on SEC.gov

American Well Corp filing history →

Source: SEC EDGAR

accession 0000950170-24-074353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.